Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 24, 2016 FBO #5266
SOLICITATION NOTICE

65 -- Fetal Bovine Serum - Sole Source Justification

Notice Date
4/22/2016
 
Notice Type
Presolicitation
 
NAICS
541990 — All Other Professional, Scientific, and Technical Services
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2016-96875
 
Archive Date
5/14/2016
 
Point of Contact
David S Dombeck, Phone: 7704882695
 
E-Mail Address
ddombeck@cdc.gov
(ddombeck@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
Sole Source Justification The Centers for Disease Control and Prevention, NCIRD/DVD, 1600 Clifton Rd. NE, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract in accordance with FAR 6.302-1 to Atlanta Biologicals, 4172 Industry Way, Flowery Branch, GA 30542, to acquire Fetal Bovine Serum used to isolate poliovirus. The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 6.302-1, "Only one responsible source and no other supplies or services will satisfy agency requirements." The National Center for Immunization and Respiratory Disease (NCIRD) has a requirement to acquire Fetal Bovine Serum for use in isolating poliovirus, determining polio immune titers, and developing new vaccines. CDC has been utilizing Atlanta Biologicals' Fetal Bovine Serum since 2011 and maintaining this specific reagent is critical to quality control testing for poliovirus isolation and titration. Replacing this specific reagent without extensive and extended validation studies would critically impact CDC's work on the Global Polio Eradication Initiative, and selecting an alternative source would take seveal months to ensure similar yields and identical results to the current product. Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency. Please forward the capability statement and/or pricing information to David Dombeck, Contract Officer, Reference 2015-80812, Centers for Disease Control, Procurement and Grants Office, ATTN: David Dombeck, MS: K-14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov. The Government will review any/all capabilities statements and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received within 15 days, negotiations will be conducted with Atlanta Biologicals, as the only source and a contract will be issued without any additional notices being posted.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-96875/listing.html)
 
Place of Performance
Address: Contractor's Facility, United States
 
Record
SN04093337-W 20160424/160422234642-8284251887c43f7e8fdaa4bbe19db3e1 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.